Seed Grant Recipients
It is often difficult for researchers to quickly pivot and explore new ideas or bring ideas from one field to bear in another. That is why we are proud to support initial investigations like these through our Seed Grants.
2022 Recipients
Jason Ackrivo, M.D., University of Pennsylvania
Implementation of a Transcutaneous CO2 Monitoring Protocol in ALS
John Altrip, Ph.D., Royal Papworth Hospital, UK
On the Validation of Tidal/End-Tidal CO2 in ALS (VOTECO2ALS)
Chelsey Carter, Ph.D., Yale University
Care Interactions in ALS: An Exploratory Study with Non-White Persons
Richard Daneman, Ph.D., University of California San Diego
Analyzing the Cerebrovascular Changes in Patients with ALS
Emma Dempster, Ph.D., University of Exeter, UK
Developing a Blood Test for the Early Detection of ALS
Christopher Donnelly, Ph.D., University of Pittsburgh
Axonal TDP-43 Dysfunction as a Pathogenic Event in ALS
Jeannine Heckmann, Ph.D., University of Cape Town, South Africa
Establishing an African ALS Research Network to Transform the ALS Landscape
Eran Hornstein, M.D., Ph.D., Weizmann Institute of Science, Israel
Uncovering the Proteome of TDP-43 Condensates in Human Neurons
Jack Humphrey, Ph.D., Icahn School of Medicine at Mount Sinai
Mapping the Genetics of TDP-43 Binding in ALS Motor Neurons
William Janes, OTD, University of Missouri
Multisite Customizable Assistive Technology Intervention
Stephen Kolb, M.D., Ph.D., The Ohio State University
Study of Axonal Contents in Mice Expressing ALS-Associated KIF5A Mutation
Marco Peviani, Ph.D., University of Pavia, Italy
Axl Receptor as Novel Biomarker Across the ALS and FTD Spectrum
Nortina Shahrizaila, Ph.D., University of Malaya, Malaysia
To Investigate the Relationship Between Exposure to Tropical Infections and ALS
Sergey Stavisky, Ph.D., University of California Davis
A Brain-Computer Interface for Restoring Speech in People with ALS
Ana Maria Vranceanu, Ph.D., Massachusetts General Hospital
An Embedded Psychosocial Service for Patients with ALS and Informal Caregivers
Vladimir Zhemkov, Ph.D., Cedars-Sinai Medical Center
A Competitive Synapto-Forming Assay to Study Sporadic ALS Using hiPSCs
